Atlas Trials

Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.

Clinical trial NCT06629233 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06629233
Sponsor
University Ghent
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Estrogen Receptor Positive Breast Cancer
Start date
2024-09-25
Primary completion
2025-12-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.